Cambridge's Deep Tech sector is booming. This year’s list of the best 56 Cambridge Deep Tech startups is an eclectic mix of hyper-growth scaleups, small creative startups and everything in between.
The last update was made on March 09, 2023.
Cambridge 10+ employees Fast-growing
Get unique, authentic analysis every Friday.
Download a carefully-curated .csv of over 9,200+ fast-growing European tech companies you can research, apply to and do business with.
Learn moreCMR Surgical is developing the next-generation surgical robotic system for minimal access surgery.
Transforming mental healthcare by unlocking the power of clinical data
Supplant is a biotechnology platform that makes sugar substitutes.
Agile Analog is a company with a mission to transform the landscape of the Analog IP market space.
Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.
Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis.
Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers.
Cambridge Epigenetix is using epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.
Artios Pharma is a independent DNA Damage Response company with a strong pipeline of novel cancer therapies.
Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.
PhoreMost is a new-model drug discovery company based in Cambridge, UK.
Biofidelity developed a revolutionary molecular diagnostics.
Sphere Fluidics develops products for use in single cell analysis and characterization, and provides associated collaborative R&D services.
Solascure is a biotechnology company focused on the development of fit for purpose, efficacious wound care products.
NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.
PetMedix is a pet therapeutics startup.
Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.
Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.
Sano Genetics is a personalised medicine research platform with data privacy and transparency at its core.
Wren Therapeutics is a biopharmaceutical company based, focused on drug discovery and development for protein misfolding diseases.
Epitopea is a transatlantic cancer immunotherapeutics company.
Mogrify® will transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies.
Diagnostics, Healthcare, Infrastructure, Early Detection, Prevention
Transine Therapeutics is a developer of a platform for physiological upregulation of proteins using targeted translation enhancers, SINEUPs.
Monocl empowers life science professionals with the complete global expert solution for impactful outreach and strategic engagement.
CellCentric is a biotechnology company that targets at deubiquitinase (DUB) enzyme for cancer therapy.
An innovator in life science reagents and tools serving life science researchers globally to achieve their mission, faster.
Zetta Genomics manages large-scale genomic data for precision medicine.
Crescendo Biologics is engaged in the development of a proprietary drug portfolio based on their VH antibody fragment platform.
PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery.
Acacia Pharma is a pharmaceutical company engaged in the R&D of supportive care drugs for cancer patients.
Revolo Biotherapeutics has developed therapies that achieve superior long-term disease remission from less frequent chronic dosing.
MISSION Therapeutics offers a platform for the development of small molecule drugs that selectively target deubiquitylating enzymes (DUBs).
FiveAI provides a software platform designed for providing a solution in urban mobility in public transport to complex urban environments.
Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.
Metrion Biosciences is a Contract Research Organization.
F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.
CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.
A multi-disciplinary team, based in Cambridge, working to solve some of the most difficult problems in biotechnology.
DIOSynVax is new technology that will significantly accelerate vaccine development and achieve dramatic improvements.
Horizon is a gene editing company that designs & engineers genetically-modified cells, applying them to advance human health.
MORPHOGEN-IX Limited is a drug discovery company founded in 2015 by Index Ventures to develop bone morphogenetic proteins
Fluidic Analytics designs, develops and manufactures tools that seek to revolutionise the way proteins are characterised.
Targeting pathways that modify RNA to deliver novel cancer therapeutics
PolyProx Therapeutics is a developer of a novel class of drug intended to provide new therapies for cancer treatment.
Exonate is a biotech company spun out of the University of Nottingham that is focused on alternative splicing of (VEGF) in ophthalmology.
Cambridge Cancer Genomics develops precision oncology solutions to transform the way cancer patients are treated.
Spectral Edge combines patented Image Fusion tech with Deep Learning to reveal more of the color, detail and clarity in any image.
Definigen provides human cells to the drug discovery sector for use in lead optimization and toxicity programs.
CS Genetics develops new technology for genomics, based on scientific insights and conceptual innovations in NGS techniques.
PetaGene’s mission is to make genomics data cheaper, faster and better.
Qkine is a specialist developer and manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications
Antibodies.com is a leading supplier of protein research tools.
Produce pure, mature and highly consistent batches of human cell types for research, toxicology and drug development.
Lightcast uses a microfluidic platform to make advances towards unique clinical approaches, new therapies, and innovative products.
Nemesis Bioscience is a new biopharmaceutical company .
Download a carefully-curated .csv of over 9,200+ fast-growing European tech companies you can research, apply to and do business with.
⚠️ Price goes up to €99 on March 23
Our Clients
Forget all about Brexit. Europe's tech capital is still booming with fintech at its core.
In Berlin, a new startup is founded every 20 minutes. What else is there to say?
Under President Macron's new regime, the Paris start-up scene is flying higher than ever before.